Prestige Care Pharmacy, Inc – Trademark Portfolio

Entity Type: 03

Prestige Care Pharmacy, Inc holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 2 filings in this category. The portfolio also extends into Class 21 (Housewares) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PENTA CLEANSE. The owner is based in Brooklyn, NY.

1190 Gravesend Neck Rd.

Brooklyn, NY 11229

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Prestige Care Pharmacy, Inc's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (2 filings)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

Frequently Asked Questions

How many trademarks does Prestige Care Pharmacy, Inc have?

Prestige Care Pharmacy, Inc has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does Prestige Care Pharmacy, Inc file in?

Prestige Care Pharmacy, Inc files trademarks across 2 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 21 (Housewares). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are Prestige Care Pharmacy, Inc's most well-known trademarks?

Prestige Care Pharmacy, Inc's registered trademark portfolio includes well-known marks such as PENTA CLEANSE. These are among 1 currently registered trademark in the portfolio.

What is Prestige Care Pharmacy, Inc's trademark registration success rate?

Prestige Care Pharmacy, Inc has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.